McDermott Will & Emery

McDermott Will & Emery

As a leading international law firm, McDermott Will & Emery propels the success of the world’s most respected, dynamic, and important life sciences organizations, and helps clients find creative and unexpected solutions in the most complex markets.  An incubator for collaboration, we partner with life sciences organizations at the forefront of innovation to foster unique partnerships and transformative business ventures.  Together, we fuel missions, knock down barriers, and shape markets.

We represent a wide spectrum of industry players, from global industry leaders in the biotech, medical device, digital health, and pharmaceutical space to start-ups, and everything in between.

We are committed to engaging clients as a trusted, knowledgeable, and innovative advisor.  This commitment is at the core of our business.  With more than 1,400 lawyers across eight countries and 21 office locations, including Boston and Paris, we offer comprehensive, cross-border services to life sciences clients.  Our life sciences team is comprised of more than 150 lawyers with demonstrated strength across intellectual property, regulatory (including FDA and privacy), transactional, and litigation law.  Combined with lawyers from our top-ranked health law practice, we work at the juncture of health, technology, and life sciences, and we understand the issues that matter when it comes to achieving your mission and solidifying your position in the market.

Our attorneys regularly advise and assist non-US clients as they plan, structure, and execute the establishment of their U.S. presence and operations.  Our team has the depth of talent and skill to meet the legal needs of life sciences companies at every stage of development, and throughout the most complex life sciences transactions.  Our team of consultants at McDermott+Consulting supports life sciences companies in determining their reimbursement pathway. This combination of resources makes us uniquely qualified to help you move business initiatives across the finish line and anticipate what’s next.

To learn more, visit